Group 1 - ZTE Corporation plans to invest 200 million RMB to subscribe to the Guangdong-Hong Kong-Macao Greater Bay Area Venture Capital Guidance Fund, focusing on areas supported by national policies such as new generation information technology and biotechnology [1] - Huayi Jewelry's subsidiary has reported overdue loans totaling 200 million RMB due to tight liquidity, with a cumulative overdue principal of 254 million RMB [2] - Guangzhou Baiyunshan Pharmaceutical's subsidiary has received approval for the consistency evaluation of Alfacalcidol soft capsules, which are used to treat calcium metabolism disorders [3] Group 2 - Kunming Pharmaceutical Group reported a 21.72% decline in revenue to 6.577 billion RMB and a 46% drop in net profit to 350 million RMB for 2025 [4] - Jiantou Energy's application for a specific stock issuance has been approved by the Shenzhen Stock Exchange [5] - Jinchuan Titanium Industry's subsidiary has temporarily suspended its sulfuric acid production due to reduced demand [6] Group 3 - Kelun Pharmaceutical's subsidiary has received approval for a new indication for its antibody-drug conjugate, which is used to treat advanced hormone receptor-positive breast cancer [7] - Fawer Co., Ltd. has completed the relocation of its Chongqing Yuantai Shock Absorber Company and commenced production [8] - Jiuzhoutong's subsidiary has received acceptance for the listing application of Betahistine Hydrochloride tablets [9] Group 4 - Zhongguancun plans to build a traditional Chinese medicine and raw material drug production base in Jiamusi City, Heilongjiang Province [11] - China Wuyi announced that part of its land in Kenya has been requisitioned by the government, with compensation of approximately 6.25 million RMB [12] - Times Electric reported a 15.46% increase in revenue to 28.761 billion RMB and a 10.88% increase in net profit to 4.105 billion RMB for 2025 [13] Group 5 - Top Cloud Agriculture's shareholder has received regulatory measures from the Zhejiang Securities Regulatory Bureau for failing to timely disclose shareholding changes [14] - Xinwanda's subsidiary has reached a settlement in a lawsuit involving over 2.314 billion RMB, with an estimated impact of 500 to 800 million RMB on net profit for 2025 [15] - Dongrui Co., Ltd. reported a 25.19% increase in pig sales revenue in January, totaling 214 million RMB [16] Group 6 - Tianjin Tianshi reported a 3.08% decline in revenue to 8.236 billion RMB, while net profit increased by 15.68% to 1.105 billion RMB for 2025 [17] - Wantong Expressway plans to invest approximately 5.42 billion RMB in the renovation and expansion of the Lianhuo Expressway [18] - Qiaoyin Co., Ltd. has pre-qualified for a sanitation integration service project worth approximately 73.8 million RMB [20] Group 7 - Jindi Co., Ltd. plans to acquire 100% equity of Yuni Precision for 116 million RMB, focusing on precision stamping products [21] - Heng Rui Medicine's HRS-4642 injection has been included in the list of breakthrough therapeutic varieties [22] - Tongde Chemical has had some assets frozen due to a financing lease dispute [23] Group 8 - Zhongli Co., Ltd. is establishing an industrial fund with a total commitment of approximately 408.76 million RMB, focusing on new materials and artificial intelligence [24] - Tianbang Food reported a 9.93% increase in pig sales revenue in January, totaling 674 million RMB [25] - New Hope reported a 10.03% decrease in pig sales revenue in January, totaling 1.628 billion RMB [26] Group 9 - Tainkang's subsidiary has received a drug registration certificate for Minoxidil topical solution [27] - Lihua Co., Ltd. reported a 9.8% increase in chicken sales revenue in January, totaling 1.289 billion RMB [28] - Guojitong General reported a 45.71% increase in net profit to 58.52 million RMB for 2025 [29] Group 10 - Zhixin Co., Ltd. plans to invest up to 1.1 billion RMB in an automotive stamping and welding parts project [30] - Chuangyuan Technology's subsidiary has pre-qualified for a National Grid project worth approximately 94.77 million RMB [31] - Lisheng Pharmaceutical's adenine phosphate raw material has passed the listing application [32] Group 11 - Tongguang Cable's subsidiary has pre-qualified for a National Grid project worth approximately 108 million RMB [33] - Zhenghong Technology reported a 7.74% increase in pig sales revenue in January, totaling 14.35 million RMB [34] - Pengding Holdings reported a 0.07% decrease in consolidated revenue in January, totaling 2.701 billion RMB [35] Group 12 - Hongri Pharmaceutical has received approval for clinical trials of its injectable drug for acute pancreatitis [36][37] - Xinhua Medical has decided to terminate the acquisition of a 36.19% stake in Wuhan Zhongzhi Biotechnology [38] - Tianyu Bio reported an 11.23% decrease in pig sales revenue in January, totaling 54.29 million RMB [39]

证券之星消息，时代电气近日即将发布2025年年报，根据2月6日发布的业绩快报，归属净利润盈利 41.053亿元，同比增长10.88%。该数据略低于大多数分析师的预期，此前分析师普遍预期2025年净利润 为盈利42.92亿元左右。 业绩快报公告中对经营业绩和财务状况情况的说明： （一）报告期的经营情况、财务状况及影响经营业绩的主要原因 报告期内，公司紧跟"交通强国"、"双碳"等重大国家战略，聚焦增收创效重要领域和关键环节。以技术 研发为核心，秉持"高质量经营，高效率运营"理念，坚持"同心多元化"战略，在夯实提升轨道交通业务 的基础上，创新发展新兴装备产业，实现了公司的稳健发展。 报告期内，公司实现营业收入人民币 2,876,071 万元，同比增长 15.46%；实现营业利润人民币 485,590 万元，同比增长 13.30%；实现利润总额人民币 488,340 万元，同比增长 13.13%；实现归属于母公司所 有者的净利润人民币 410,535 万元，同比增长 10.88%；实现归属于母公司所有者的扣除非经常性损益 的净利润人民币390,877 万元，同比增长 21.18%；实现基本每股收益人民币 3.00 元 ...

格隆汇2月6日丨时代电气(03898.HK)发布2025年度业绩快报，报告期内，公司实现营业收入人民币 287.61亿元，同比增长15.46%；实现归属于母公司所有者的净利润人民币41.05亿元，同比增长 10.88%；实现归属于母公司所有者的扣除非经常性损益的净利润人民币39.09亿元，同比增长21.18%； 实现基本每股收益人民币3.00元，同比增长14.50%；实现加权平均净资产收益率9.84%，同比增长0.53 个百分点。 ...

智通财经APP讯，时代电气(03898)公布2025年度业绩快报，营业总收入约287.61亿元，同比增长 15.46%;归属于母公司所有者的净利润约41.05亿元，同比增长10.88%;归属于母公司所有者的扣除非经常 性损益的净利润约39.09亿元，同比增长21.18%;基本每股收益3元。实现加权平均净资产收益率9.84%， 同比增长0.53个百分点。 ...

智通财经APP讯，时代电气(03898)公布2025年度业绩快报，营业总收入约287.61亿元，同比增长 15.46%;归属于母公司所有者的净利润约41.05亿元，同比增长10.88%;归属于母公司所有者的扣除非经常 性损益的净利润约39.09亿元，同比增长21.18%;基本每股收益3元。实现加权平均净资产收益率9.84%， 同比增长0.53个百分点。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責， 對 其 準 確 性 或 完 整 性 亦 不 作 任 何 聲 明，並 明 確 表 示 概 不 就 因 本 公 告 全 部 或 任 何 部 分內容而產生或因依賴該等內容而引致的任何損失承擔任何責任。 （於中華人民共和國註冊成立的股份有限公司） 增 減 （股份代號：3898） 2025年度業績快報公告 株洲中車時代電氣股份有限公司（「本公司」或「公司」，連同其附屬公司統稱「本集團」） 根 據《香 港 聯 合 交 易 所 有 限 公 司 證 券 上 市 規 則》（「上市規則」）第13.09、第13.10B條 及 香港法例第571章《證券及期貨條例》第XIVA部項下之內幕消息條文（按上市規則定義） 作 出 本公告。 本公告所載本集團2025年度主要財務數據為初步核算數據，未經會計師事務所審計， 經審計的數據以本公司2025年 年 度 報 告 中 披 露 的 數 據 為 準，提 請 本 公 司 投 資 者 注 意投資風險。 一、 2025年度主要財務數據和指標 單位：人民幣萬元 增 減 | 項 目 | 本報告期 | 上年同期 | 變動幅度 (%) ...

证券代码：688187（A 股） 证券简称：时代电气（A 股） 公告编号：2026-004 证券代码： 3898（H 股） 证券简称：时代电气（H 股） 株洲中车时代电气股份有限公司 2025 年度业绩快报公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 本公告所载株洲中车时代电气股份有限公司（"公司"）2025年度主要财务数 据为初步核算数据，未经会计师事务所审计，具体数据以公司2025年年度报告中披 露的数据为准，提请投资者注意投资风险。 一、2025 年度主要财务数据和指标 单位：人民币万元 | 项 目 | 本报告期 | 上年同期 | 增减变动幅度 （％） | | --- | --- | --- | --- | | 营业总收入 | 2,876,071 | 2,490,894 | 15.46 | | 营业利润 | 485,590 | 428,601 | 13.30 | | 利润总额 | 488,340 | 431,659 | 13.13 | | 归属于母公司所有者的净利润 | 410,535 | 370,259 | ...

南财智讯2月6日电，时代电气发布2025年度业绩快报，报告期内公司实现营业收入287.61亿元，同比增 长15.46%；归属于上市公司股东的净利润41.05亿元，同比增长10.88%；基本每股收益3.00元，同比增 长14.50%。 ...

时代电气公告称，2025年度公司实现营业收入287.61亿元，同比增长15.46%；营业利润48.56亿元，同 比增长13.30%；利润总额48.83亿元，同比增长13.13%；归属于母公司所有者的净利润41.05亿元，同比 增长10.88%。报告期末，资产总额721.24亿元，较期初增长11.30%；归属于母公司所有者权益424.96亿 元，较期初增长2.33%。以上数据为初步核算，未经审计，具体以2025年年报为准。 ...

从资金流向上来看，当日轨交设备板块主力资金净流入6185.26万元，游资资金净流出8354.12万元，散户 资金净流入2168.86万元。轨交设备板块个股资金流向见下表： | 代码 | 名称 | 主力净流入(元) | 主力净占比 游资净流入 (元) | | 游资净占比 散户净流入(元) | | 散户净占比 | | --- | --- | --- | --- | --- | --- | --- | --- | | 601766 中国中车 | | 1.22亿 | 11.72% | -6638.50万 | -6.40% | -5525.07万 | -5.33% | | 688485 九州一轨 | | 937.38万 | 6.49% | -717.86万 | -4.97% | -219.52万 | -1.52% | | 000925 众合科技 | | 680.64万 | 3.68% | -778.36万 | -4.21% | 97.72万 | 0.53% | | 603111 康尼机电 | | 565.69万 | 10.36% | -193.10万 | -3.54% | -372.59万 | -6.82% | | 6 ...